Rhetoric Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.70 M
- Revenue Growth 22.72%
- Profit Growth 25.60%
- Ebitda 687.65%
- Net Worth 24.08%
- Total Assets -2.03%
About Rhetoric Remedies
Rhetoric Remedies Private Limited (RRPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 February 2014 and has a history of Ten years and 11 months. Its registered office is in Varanasi, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.70 M.
Shashank Singh, Chandani Singh, and Chhaya Singh serve as directors at the Company.
Company Details
-
Location
Varanasi, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900UP2014PTC062915
-
Company No.
062915
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Feb 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Rhetoric Remedies?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shashank Singh
|
Director | 24-Feb-2014 | Current |
|
Chandani Singh
|
Director | 24-Feb-2014 | Current |
|
Chhaya Singh
|
Director | 24-Feb-2014 | Current |
Financial Performance of Rhetoric Remedies.
Rhetoric Remedies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.72% increase. The company also saw a substantial improvement in profitability, with a 25.6% increase in profit. The company's net worth Soared by an impressive increase of 24.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rhetoric Remedies?
In 2020, Rhetoric Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.70 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jul 2017 | Others | ₹0.70 M | Open |
How Many Employees Work at Rhetoric Remedies?
Unlock and access historical data on people associated with Rhetoric Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rhetoric Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rhetoric Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.